TFBS Bioscience (ROCO:6939) Pre-Tax Income : NT$-25.2 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is TFBS Bioscience Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. TFBS Bioscience's pretax income for the six months ended in Jun. 2024 was NT$-18.9 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-25.2 Mil. TFBS Bioscience's pretax margin was -20.67%.

During the past 4 years, TFBS Bioscience's highest Pretax Margin was 12.15%. The lowest was -12.09%. And the median was 3.21%.

TFBS Bioscience Pre-Tax Income Historical Data

The historical data trend for TFBS Bioscience's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TFBS Bioscience Pre-Tax Income Chart

TFBS Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

0.33

7.01

30.71

4.77

TFBS Bioscience Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pre-Tax Income	Get a 7-Day Free Trial			22.92	7.79	11.03	-6.25	-18.94

Competitive Comparison of TFBS Bioscience's Pre-Tax Income

For the Diagnostics & Research subindustry, TFBS Bioscience's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TFBS Bioscience's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where TFBS Bioscience's Pre-Tax Income falls into.

TFBS Bioscience Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

TFBS Bioscience's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-4.453	+	0	+	-0.602	+	11.185	+	-1.356
	=	4.8

TFBS Bioscience's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-25.858	+	0	+	-0.604	+	4.965	+	2.559
	=	-18.9

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-25.2 Mil.

TFBS Bioscience (ROCO:6939) Pre-Tax Income Explanation

TFBS Bioscience's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-18.938	/	91.599
	=	-20.67%

During the past 4 years, TFBS Bioscience's highest Pretax Margin was 12.15%. The lowest was -12.09%. And the median was 3.21%.

TFBS Bioscience Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of TFBS Bioscience's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

TFBS Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN

Website

https://www.tfbsbio.com

TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.

TFBS Bioscience Headlines

No Headlines